Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBF.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBF.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBF.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BQ.1.1.15EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.15ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.15ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.15EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.15EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.31EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.31ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.31ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.31EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.31EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BE.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BE.13EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BE.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BE.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BW.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BW.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BW.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BW.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BW.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BW.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BW.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BW.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FB.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
FB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FB.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
FB.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FB.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FB.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FB.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FB.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.23EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.23ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.23ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.23EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.23EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used